Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Processa Pharmaceuticals Inc (NASDAQ: PCSA) was $1.33 for the day, up 0.09% from the previous closing price of $1.33. In other words, the price has increased by $0.09 from its previous closing price. On the day, 1.6 million shares were traded. PCSA stock price reached its highest trading level at $1.33 during the session, while it also had its lowest trading level at $1.3.
Ratios:
Our analysis of PCSA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 4.82. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 25, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 07 ’24 when Young David bought 21,000 shares for $2.45 per share. The transaction valued at 51,526 led to the insider holds 79,387 shares of the business.
Young David bought 20,000 shares of PCSA for $50,504 on Feb 06 ’24. The Pres. Research & Development now owns 58,387 shares after completing the transaction at $2.53 per share. On Jan 31 ’24, another insider, Lin Patrick, who serves as the Chief Business – Strategy Off of the company, bought 2,500 shares for $2.37 each. As a result, the insider paid 5,925 and bolstered with 25,978 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCSA now has a Market Capitalization of 4331730 and an Enterprise Value of -1120555.
Stock Price History:
Over the past 52 weeks, PCSA has reached a high of $18.00, while it has fallen to a 52-week low of $1.28. The 50-Day Moving Average of the stock is -11.85%, while the 200-Day Moving Average is calculated to be -49.49%.
Shares Statistics:
PCSA traded an average of 980.59K shares per day over the past three months and 213760 shares per day over the past ten days. A total of 3.26M shares are outstanding, with a floating share count of 2.89M. Insiders hold about 11.37% of the company’s shares, while institutions hold 1.38% stake in the company. Shares short for PCSA as of 1726185600 were 73788 with a Short Ratio of 0.08, compared to 1723680000 on 104808. Therefore, it implies a Short% of Shares Outstanding of 73788 and a Short% of Float of 2.48.
